# Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

> **NCT00000609** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Arrhythmia
- Cardiovascular Diseases
- Death, Sudden, Cardiac
- Heart Diseases
- Heart Failure, Congestive
- Heart Failure

## Interventions

- **DRUG:** amiodarone
- **DEVICE:** defibrillators, implantable

## Key facts

- **NCT ID:** NCT00000609
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-05
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** — (—)
- **Last updated:** 2016-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000609, "Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00000609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
